Gujarat Kidney & Super Speciality IPO
Gujarat Kidney & Super Speciality IPO — date, price band, GMP & allotment 2025
Gujarat Kidney & Super Speciality Hospital IPO offers investors an opportunity to participate in a growing healthcare service provider focused on kidney care and multi-speciality treatments. The company plans to use the funds for expansion, medical equipment, and working capital needs. With rising demand for quality healthcare services, especially in specialized treatments, the IPO may attract investors looking for exposure in the healthcare sector. Investors should review financials before applying.
Stock price
Gujarat Kidney & Super Speciality is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 15 September.
- Open 22 Dec 2025
- Close 24 Dec 2025
- Allotment 26 Dec 2025
- Refund/credit 29 Dec 2025
- Listing 30 Dec 2025
Issue summary
The terms of the offer, as filed.
| IPO Dates | 22 to 24 Dec, 2025 |
|---|---|
| Price Band | ₹108 to 114 |
| Face Value | ₹₹2 |
| Lot Size | 128 Shares |
| Issue Size | ₹250.80 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE & NSE |
| Employee Discount | NA |
| Registrar | MUFG Intime India Private Limited |
| Min Investment | ₹ 14,592 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 128 shares at the ₹114 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 128 | ₹14,592 |
| Retail (max) | 13 | 1,664 | ₹1,89,696 |
| S-HNI (min) | 14 | 1,792 | ₹2,04,288 |
| S-HNI (max) | 68 | 8,704 | ₹9,92,256 |
| B-HNI (min) | 69 | 8,832 | ₹10,06,848 |
Three years of numbers
All figures in ₹ crore, as reported in the Gujarat Kidney & Super Speciality offer document.
| Metric | 30 JUN 25 | 31 MAR 25 | 31 MAR 24 |
|---|---|---|---|
| Revenue | 15.27 | 40.40 | 5.48 |
| EBITDA | 8.63 | 16.55 | 1.95 |
| Net Profit | 5.40 | 9.50 | 1.71 |
| Debt | 4.03 | 3.88 | 1.94 |
| Assets | 61.59 | 55.34 | 20.53 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Gujarat Kidney & Super Speciality RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
Gujarat Kidney & Super Speciality IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Post-Issue |
|---|---|
| EPS (₹) | ₹1.85 |
| P/E Ratio (x) | 61.62 |
| Market Cap at Offer Price (₹ Cr) | ₹332.76 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹114 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
₹225.75 Cr of the issue is earmarked to named objects.
About the company
The hospital offers a wide range of services including nephrology, urology, cardiology, intensive care, and other super speciality treatments. It is equipped with advanced dialysis units, operation theatres, and diagnostic facilities to support comprehensive patient care. The business model is primarily service-driven, generating revenue through consultations, procedures, diagnostic services, and inpatient care. By maintaining a balance between affordability and quality, the hospital aims to serve both urban and semi-urban populations while building long-term trust and relationships with patients.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
+91 265 298 4800
The bankers & the filings
Who is running the book, and the documents this page is built from.
Gujarat Kidney & Super Speciality IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Nirbhay Capital Services
1 issue handled1 of their issues has listed so far, and 0 opened above the issue price (average 0%). That is too small a sample to read as a hit rate.
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Gujarat Kidney & Super Speciality?
The current Grey Market Premium is ₹55, or 10%% over the issue price.
What is the Gujarat Kidney & Super Speciality IPO price band?
₹108 to ₹114, on a face value of ₹₹2.
When is the allotment?
The basis of allotment is 26 December 2025, with listing on 30 December 2025.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — MUFG Intime India Private Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
